Eric Smith

16PUBLICATIONS
190CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical virologyImmunogenetics (incl. genetic immunology)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 20, 2026
Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial.

|Nov 02, 2025
Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies.

Elizabeth J Carstens, Kazuki Takahashi, Naoya Sakamoto

|Sep 08, 2025
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors.

Elliott J Brea, Simon Baldacci, Neil Savage

|Aug 05, 2025
Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy.

Simon Baldacci, Elliott J Brea, Francesco Facchinetti

|May 08, 2025
Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition.

Zackery A Ely, Zachary J Kulstad, Gurcan Gunaydin

|Feb 10, 2025
Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom's Macroglobulinemia.

Romanos Sklavenitis-Pistofidis, Yoshinobu Konishi, Daniel Heilpern-Mallory

Pageof 3

Frequent Collaborators

3 joint publications

Mette Staehr

3 joint publications

Navin R Mahadevan

3 joint publications

Elena V Ivanova

3 joint publications

Pasi A Jänne